Profound Medical Corp. provided earnings guidance for full-year 2024. For the period, company expects total revenue to be in the range of $11.0 million to $12.0 million, which represents 53% to 67% growth compared to its prior year revenue.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
10.88 CAD | +0.65% | -5.56% | -1.98% |
May. 15 | Transcript : Profound Medical Corp. - Shareholder/Analyst Call | |
May. 14 | Sector Update: Health Care Stocks Steady Premarket Tuesday | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.98% | 194M | |
+11.14% | 226B | |
+15.21% | 198B | |
+18.53% | 142B | |
+29.49% | 111B | |
+2.40% | 65.26B | |
+17.15% | 54.36B | |
+4.96% | 50.94B | |
+9.24% | 44.8B | |
+3.48% | 36.8B |
- Stock Market
- Equities
- PRN Stock
- News Profound Medical Corp.
- Profound Medical Corp. Provides Earnings Guidance for Full-Year 2024